Medable Secures $304M in Series D Funding

Clinical research company Medable has secured $304 million in Series D funding, marking its fourth round since 2020, giving the firm a valuation of just over $2 billion. Dr. Michelle Longmire, CEO and Co-founder, Medable joined Cheddar's Opening Bell to discuss the future of the company.
We use cookies and similar technologies on this site to collect identifiers, such as IP address, and cookie and device IDs as described in our Privacy Policy.